FIBRIN PARTICLES AND METHODS OF FORMING FIBRIN PARTICLES

    公开(公告)号:US20210171587A1

    公开(公告)日:2021-06-10

    申请号:US17112661

    申请日:2020-12-04

    IPC分类号: C07K14/435 C07K14/75

    摘要: The present disclosure generally relates to compositions comprising fibrin and to methods of forming such compositions. In an embodiment, a method of forming fibrin particles is provided. The method includes introducing a buffer, a fibrinogen solution, and a thrombin solution to a first end of a microfluidic device to form a mixture, the buffer comprising one or more amino acids. The method further includes contacting the mixture with a fluorocarbon oil and a surfactant to form fibrinogen-containing particles, and applying positive pressure to the microfluidic device to cause the fibrinogen-containing particles to flow towards a second end of the microfluidic device. The method further includes collecting the fibrinogen-containing particles at the second end of the microfluidic device; and polymerizing the fibrinogen-containing particles to form fibrin particles.

    FIBRIN PARTICLES AND METHODS OF FORMING FIBRIN PARTICLES

    公开(公告)号:US20240317823A1

    公开(公告)日:2024-09-26

    申请号:US18737141

    申请日:2024-06-07

    IPC分类号: C07K14/435 C07K14/75

    CPC分类号: C07K14/435 C07K14/75

    摘要: The present disclosure generally relates to compositions comprising fibrin and to methods of forming such compositions. In an embodiment, a method of forming fibrin particles is provided. The method includes introducing a buffer, a fibrinogen solution, and a thrombin solution to a first end of a microfluidic device to form a mixture, the buffer comprising one or more amino acids. The method further includes contacting the mixture with a fluorocarbon oil and a surfactant to form fibrinogen-containing particles, and applying positive pressure to the microfluidic device to cause the fibrinogen-containing particles to flow towards a second end of the microfluidic device. The method further includes collecting the fibrinogen-containing particles at the second end of the microfluidic device; and polymerizing the fibrinogen-containing particles to form fibrin particles.